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development on mesoporous silica nanoparticles†
Alden M. Clemments,a Carlos Muniesa,b Christopher C. Landry*a and Pablo Botella*bThe composition of the protein corona formed on mesoporous silica
nanoparticles with several surface modiﬁcations was characterized.
Low MW serum proteins were preferentially adsorbed, and PEGylated
nanoparticles did not adsorb protein regardless of PEG chain length.Nanomedicine is continuously providing new single and
multifunctional alternatives to traditional pharmaceutical
delivery and treatment, enhancing both therapeutic activity and
selectivity to pathological tissues, as well as providingmolecular
recognition and biosensing features.1,2 Unfortunately, the
stability of most nanomaterials in biological uids is still a
challenge to be solved, and the incorporation of stable nano-
particles into the bloodstream provokes a strong reaction with
serum proteins, lipids, and small molecules, forming a shell of
aggregated compounds known as the protein corona.3 The very
high surface to volume ratio of nanomaterials dramatically
boosts the adsorption process, changing their surface proper-
ties. This corona denes the biological identity of the nano-
materials and determines their nal physiological fate. In the
case of intravenous (iv) injection, protein adsorption drives
nanoparticle uptake by monocytes andmacrophages, leading to
their distribution to the reticuloendothelial system (RES) and
compromising their therapeutic eﬃcacy.4–7
Independent of the nature of the nanomaterial, the protein
corona grows in a few minutes over the particles and may evolve
for several days.8–10 It has a complex composition, oen consisting
of several dozens of proteins. Some of these proteins are loosely
bound to particle surface (the “so corona”), but, so far, most of
the studies of this coatinghave been carried out over a short list of
proteinsrmly attached toparticles forming the “hardcorona”, as
this represents the protein signature of the nanomaterial in aont, Burlington, VT 05405, USA. E-mail:
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8given environment.11–15 These studies have shown that the total
protein concentration in biological uids may change the
composition of the corona, although, surprisingly, the concen-
tration of a specic protein does not determine its presence in the
biological layer (e.g., human serumalbumin is themost abundant
protein in serum but is actually in minority around nano-
particles).16,17Moreover, the role of targetingmoleculesdecorating
the nanoparticle surface depends on this protein covering, as the
interaction with specic receptors may be seriously hindered.18
Changing nanoparticle properties, such as material,16
size,12,19–21 and surface chemistry,12,21,22 may alter the corona
composition. Interestingly, the most widely applied strategy to
block nonspecic protein adsorption on nanoparticles is to
modify the surface by graing linear chains of poly(ethylene
glycol) (PEG).21,23 In fact, diﬀerent studies support that PEGyla-
tion of nanomaterials diminishes interaction with serum
proteins, decreasing the rate of phagocytic uptake and increasing
blood residence time.24,25 Additionally, proteomics analysis has
been performed on a wide range of organic and inorganic
nanomaterials, such as polystyrene,11,15,16 hydrogels,22 carbon
nanotubes,26 gold,9,21 SPIONs,27 quantum dots,28,29 and amor-
phous silica nanoparticles.16,17,19,20,22 However, so far, no investi-
gation has been reported on the protein corona on mesoporous
silica nanoparticles (MSNs). In recent years, mesoporous silica
materials havebeenconsidered tobe excellent platforms fordrug
delivery systems.30–33 The large internal porosity of MSNs favors
the loading of signicant quantities of therapeutic molecules
within the pore channels. Furthermore, nanoparticle shape and
size, aswell as pore structure, canbe easily tuned throughvarious
synthetic strategies.34,35 Finally, the silanol-containing surface
canbe easily functionalized, introducing additional features that
allow for stimuli-responsive controlled drug release.36 Shi et al.37
highlighted the eﬀect of PEGylation of MSNs on human serum
albumin binding and cellular responses, concluding that PEG
graing greatly decreased protein binding to MSNs as well as
macrophage uptake. Nevertheless, additional work is needed to
completely characterize the protein corona onMSNs, and how it
evolves as a function of nanoparticle modication.This journal is © The Royal Society of Chemistry 2014
Communication RSC AdvancesIn the present work, we have carried out a complete
compositional study of the protein corona adsorbed onto 50 nm
MSNs aer incubation (1 h) in Dulbecco's Modied Eagle's
Medium containing 10% fetal bovine serum (FBS). A proteomic
analysis using one-dimensional sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE) and electrospray
liquid chromatography mass spectrometry (LC-MS) has been
performed on the protein extract isolated from reacted nano-
particles. Quantitative results for most abundant proteins have
been obtained by comparing proteomic distribution with ther-
mogravimetric analysis (TGA) data. Furthermore, we have also
investigated the inuence of particle surface modication on
the protein adsorption process by studying amine and carbox-
ylate-modied MSNs, and we have used diﬀerent chain length
PEG molecules in order to evaluate the eﬀect of PEGylation on
particle reactivity.
Highly ordered mesoporous silica nanoparticles (MSNs)
were synthesized, with BET surface area about 700–900 m2 g1.
These MSNs were then used as the base material for further
modications (Fig. 1). The surface areas decreased slightly upon
modication with amino- and carboxylate-silanes; however, the
modication of the MSNs with PEG chains severely reduced the
surface area. This is most likely due to surface shielding and
pore blocking eﬀects, consistent with the fact that the surface
area for the material modied with a short PEG chain (241 m2
g1) was higher than for the long PEG chain (55 m2 g1). MSNs
with average diameters of 50–55 nm (Table 1 and Fig. S1 and
S2†) were obtained with low polydispersion, as characterized by
transmission electron microscopy (TEM) and dynamic light
scattering (DLS) techniques. Interestingly, the MSNs did notTable 1 Characterization of as-prepared and FBS-exposed MSN sample
Sample N2 physisorption Coverage TGA (wt%
MSN–X
SBET
(m2 g1)
dpore
(nm) (mmol g1) (mmol m2)a
As
made
F
e
–OH 885 3.9 — — 8.0 1
–NH2 734 3.1 2.43 3.31 8.4 2
–COOH 813 3.4 2.10 2.58 14.4 1
–PEG3–OCH3 241 2.7 0.87 3.61 23.5 2
–PEG24–OCH3 55 1.9 0.24 4.36 31.1 2
a Moles of organic group (mmol g1) divided by SBET (m
2 g1). b Particles
buﬀered saline. c Hydrodynamic diameter determined by dynamic light s
Fig. 1 Synthesis scheme for the materials used in these experiments.
This journal is © The Royal Society of Chemistry 2014show signicant changes in diameter as measured by DLS aer
exposure to 10% FBS solution, in contrast with the results of
Monopoli et al. who described a 8–12% increase in the hydro-
dynamic diameter of amorphous silica nanoparticles aer
protein adsorption.16 However, the latter study used much
larger particles (200 nm), which likely led to diﬀerent amounts
of protein being adsorbed.20
Analysis using TGA, conrmed with elemental analysis,
showed that the as-made materials (surface-modied but not
yet exposed to protein) contained varying weight percentages of
organic material. The total organic content of the amine- and
carboxylate-modied MSNs was lower than that of the PEGy-
lated MSNs, but this was primarily due to the increased mass of
the PEG silanes. When calculated as mmol silane per g MSN,
the trend is reversed, with more of the smaller silanes than the
PEGs, which is consistent with the fact that the smaller silanes
are able to access and modify the internal pore surfaces, while
the larger PEG silanes primarily modify the external surface and
the mouths of the pores, as described above. Finally, when the
moles of each silane are scaled according to the available
surface area (SBET), which is more consistent with the portion of
the MSN that interacts with the protein solution, the values of
mmol m2 are nearly the same, indicating that the surface
coverages are similar regardless of the type of modication.
The base material had a zeta potential of 12.4 mV, which is
consistent with a bare silica surface in solution. Modication
with amine groups led to a less negative zeta potential (7.9
mV) due to the protonation of amines in the neutral solution
used for measurement; the fact that the value is not positive
indicates that the surface has not been completely modied.
Similarly, MSNs modied with PEG chains showed less negative
zeta potentials due to the two-step process used to attach the
PEG chains, which involved rst modifying the surface with
amines followed by reaction with N-hydroxysuccinimide (NHS)-
modied PEG3 or PEG24. Thus the zeta potentials of the PEG-
modied MSNs reect the fact that both silanol and amine
groups remain on the surface in addition to PEG. As expected,
modication with carboxylate groups led to a more negative
zeta potential (15.4 mV).
Upon exposure to 10% FBS solution, the zeta potentials of
the unmodied, –NH2 modied, and –COOH modied MSNs
became substantially less negative, consistent with thes
organic) Diameterc (nm) z-potential (mV)
BS-
xposedb
Protein
adsorbed
As
made
FBS-
exposedb
As
made
FBS-
exposedb D
8.1 10.1 53.1  27.0 50.6  26.0 12.4 4.8 +7.6
2.8 14.4 51.6  23.3 54.0  27.3 7.9 4.0 +3.9
6.7 2.3 50.5  22.9 51.4  23.0 15.4 10.2 +5.2
3.3 — 49.9  23.9 55.6  27.0 9.4 8.7 +0.7
8.9 — 51.4  26.8 54.4  27.0 5.2 5.9 0.7
placed in solutions containing 10% fetal bovine serum in phosphate-
cattering.
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RSC Advances Communicationformation of a protein corona. The corona led to a shielding
eﬀect that altered the surface charge of the particles, which has
been reported by other authors using diﬀerent materials.9,22 In
the case of the PEGylatedMSNs, there was no signicant change
in zeta potential and therefore surface charge, leading to the
conclusion that no signicant protein corona had been formed.
This was conrmed using thermogravimetric analysis (TGA) on
MSNs before and aer exposure to 10% FBS. Unmodied and
–NH2 modied MSNs showed signicant amounts of adsorbed
protein (10.1 and 14.4 wt%), with a lesser amount of protein
adsorbed by the –COOH modied MSNs (2.3 wt%). In contrast,
PEGylated MSNs showed no signicant protein adsorption.
Previous studies used long PEG chains,23,26,37 but we show here
that even a PEG trimer was suﬃcient to prevent the formation of
a protein corona. This is relevant to the use of porous nano-
particles, because the decrease in surface area and therefore the
extent of pore blockage was much smaller for –PEG3 than for
–PEG24 modied MSNs.
The protein corona on each type of MSN in these studies was
characterized by combining LC-MS and TGA data. Protein was
released from the particles for analysis using a typical dena-
turation process (see ESI†). The amount of protein released by
this technique was consistent with the TGA data, as conrmed
by the bicinchoninic acid (BCA) assay. While other studies have
shown the wide range of proteins that adsorb onto the surfaces
of various types of nanoparticles, most of these results have
been presented in terms of relative amounts of each. For
example, Monopoli et al.16 applied a normalization to the
spectral counts obtained from LC-MS data that took into
account the molecular weight of each protein, but this does not
describe the mass of each adsorbed protein. Consequently, inTable 2 Most common proteins found on porous 70 nm nanoparticles
Protein Mw (kDa) pI
MSN–OH
NSpCb N
Apolipoprotein A-II 11 8.10 0.248 25
Apolipoprotein C-III 11 5.11 0.044 4
Hemoglobin subunit a 15 8.44 0.000 0
Hemoglobin fetal subunit b 16 7.03 0.073 7
Hemoglobin subunit b 16 6.74 0.061 6
Apolipoprotein A-I-like 24 5.43 0.089 9
ACTA2 protein-like 26 5.24 0.060 6
Apolipoprotein A-I 30 5.97 0.137 13
Collectin-43 34 5.12 0.000 0
a-2-HS-glycoprotein 38 5.50 0.151 15
Protein AMBP 39 7.62 0.000 0
Actin, a skeletal muscle 42 5.23 0.037 3
LMW isoform of kininogen-1 48 6.62 0.000 0
Serum albumin 69 6.18 0.017 1
Prothrombin (fragment) 71 6.33 0.000 0
Inter-a-trypsin inhibitor
heavy chain H2
106 7.94 0.000 0
Total protein deposit
from TGA (wt%)
10
a MSN–PEGn–OCH3 materials did not show a weight loss from TGA and ar
calculated as described in the text. c NSpC  TGA ¼ amount of each prot
29136 | RSC Adv., 2014, 4, 29134–29138these studies, spectral counts from LC-MS experiments were
normalized to obtain the relative percentages of each protein on
the surface, and this value was then multiplied by the weight of
protein determined by TGA to obtain the mass of each adsorbed
protein (eqn (1))
SpCi
Xn
i
SpCi
 TGA 10 (1)
In this equation, SpCi is the spectral counts associated with a
particular protein, and TGA is the weight percent of adsorbed
protein in the particular MSN sample. The factor of 10 is added
to bring the units to mg protein per g of particles. The rst part
of the equation is dened as normalized spectral counts,
abbreviated NSpC. SpC values and a heat map of the complete
set of adsorbed proteins for unmodied, –NH2 modied, and
–COOHmodied MSNs are, respectively, shown in Table S1 and
Fig. S3,† and a subset of the most common proteins, dened as
those with NSpC  TGA of 3.00 or higher, is shown in Table 2. It
is apparent that although many proteins are present in 10%
FBS, the subset of adsorbed proteins in each type of MSN's hard
corona is much smaller.
More than 86 wt% of the adsorbed proteins was accounted
for by only eight proteins (highlighted in Table 2) in the
unmodied MSN sample, and the same proteins accounted for
more than 60 wt% in the –COOH modied MSN sample
although the total amount of adsorbed protein was signicantly
less. The zeta potential of the surface did not appear to be a
signicant factor in determining the type of protein adsorbed,
because the isoelectric points (pIs) of the adsorbed proteins
varied between 5.1 and 8.1. The pI values of most of the proteinswith various surface modiﬁcationsa
MSN–NH2 MSN–COOH
SpC  TGAc NSpC NSpC  TGA NSpC NSpC  TGA
.1 0.194 27.9 0.140 3.21
.48 0.028 4.08 0.000 0.00
.00 0.045 6.48 0.024 0.55
.39 0.032 4.67 0.186 4.29
.16 0.000 0.00 0.096 2.21
.03 0.000 0.00 0.045 1.04
.06 0.000 0.00 0.010 0.24
.8 0.017 2.49 0.090 2.08
.00 0.026 3.74 0.000 0.00
.3 0.100 14.4 0.040 0.93
.00 0.061 8.82 0.000 0.00
.75 0.000 0.00 0.015 0.35
.00 0.025 3.58 0.000 0.00
.71 0.058 8.34 0.018 0.42
.00 0.041 5.90 0.000 0.00
.00 0.043 6.21 0.007 0.16
.1 14.4 2.3
e not included here. b NSpC ¼ normalized spectral counts from LC-MS,
ein found on particle, expressed as mg protein per g particles.
This journal is © The Royal Society of Chemistry 2014
Communication RSC Advancesare below 7, so they are negatively charged at physiological pH.
However, deposition on negatively charged nanoparticles does
not correlate with protein charge, showing that electrostatic
eﬀects alone are not the major driving force regulating MSN–
protein interactions. This is consistent with the composition of
the protein corona on other particles.20,38
However, it is interesting to note that the molecular weights
of these eight proteins were among the smallest of the entire set
of identied proteins, with weights all below 38 kDa (Table 2
and Fig. S4†) because these samples all had large internal
surface areas, there may be a size-exclusion eﬀect in which
larger proteins are prevented from adsorbing in large amounts
by the diameter of the pores. This makes sense in light of other
studies of the protein corona on dense (non-porous) silica, in
which a larger fraction of the adsorbed proteins had higher
molecular weights. In the case of –NH2 modied MSNs the
protein distribution is more varied. The eight proteins high-
lighted in Table 2 only account for 37 wt% of the total amount of
adsorbed protein, and more proteins with higher molecular
weights were adsorbed. Again, pI does not appear to play an
important role here. The reason for this discrepancy could be in
the dominant role of surface primary amines in the nonspecic
binding of serum proteins on nanoparticles, as has been
described in the literature.39,40 Additionally, as noted above, the
larger surface area of the –NH2 modied MSNs indicate that the
pore surfaces aremore accessible to proteins, whichmay allow a
wider variety of low molecular weight proteins to be trapped in
the pores. Finally, PEGylated samples did not show any protein
adsorption by LC-MS or TGA, even in the case of –PEG3modied
particles with surface areas of 241 m2 g1. This conrmed the
ability of PEG chains to prevent protein adsorption and there-
fore to prevent nanoparticle aggregation in biological medium.
In conclusion, we have characterized protein adsorption
onto mesoporous silica nanoparticles (MSNs) modied with
–NH2, –COOH, –PEG3, and –PEG24 groups as well as onto
unmodied MSNs, using LC-MS and TGA to determine the total
mass of each protein adsorbed. The results are somewhat
diﬀerent from other studies performed on dense (non-porous)
silica nanoparticles. Most of the adsorbed proteins had low
molecular weights, and the –NH2 modied MSNs had the
largest variety of proteins. The pI values of the adsorbed
proteins were mostly below physiological pH (7.4), although
there was not a strong correlation between pI and the type of
surface modication. Finally, PEGylated particles did not
adsorb protein, regardless of chain length.
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